Exp Clin Endocrinol Diabetes 2008; 116: S56-S58
DOI: 10.1055/s-2008-1081493
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Polymorphisms in Perilipin Gene (PLIN) are not Associated with Obesity and Weight Variation in People with High Risk of Type 2 Diabetes

A. Bergmann 1 [*] , J. Li 2 [*] , M. Reimann 2 , T. Hentrich 2 , M. Hanefeld 2 , S. R. Bornstein 2 , P. E. H. Schwarz 2
  • 1Health Care Centre of Medical Faculty Carl-Gustav-Carus of the Technical University Dresden, Dresden, Germany
  • 2Department of Endocrinopathies and Metabolic Diseases, Medical Faculty Carl-Gustav-Carus of the Technical University Dresden, Dresden, Germany
Further Information

Publication History

received 13.05.2008

accepted 20.06.2008

Publication Date:
05 September 2008 (online)

Abstract

Perilipins are hormonally regulated phosphorylated proteins that coat the intracellular lipid storage droplet [1]. They are essential for the regulation of triglyceride deposition and mobilization [2] [3]. The human perilipin gene (PLIN) is located to 15q26.1, near the susceptibility loci for obesity, and insulin-dependent diabetes mellitus, and hypertriglyceridemia. Therefore, it is considered as a candidate gene for these diseases [4]. Some studies shown that lower level of perilipin protein was displayed in obese than lean subjects [5] and polymorphisms in PLIN were associated with obesity in American and Spanish white women as well as in Korean [6] [7]. But some other studies showed that, this association was not significant in Chinese [8] and French [9]. The aim of the current study was to examine whether the associations manifested in a German population with high risk of type 2 diabetes.

References

  • 1 Greenberg AS, Egan JJ, Wek SA. et al . Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets.  J Biol Chem. 1991;  266 11341-11346
  • 2 Brasaemle DL, Rubin B, Harten IA. et al . Perilipin A increases triacylglycerol storage by decreasing the rate of triacylglycerol hydrolysis.  J Biol Chem. 2000;  275 38486-38493
  • 3 Mottagui-Tabar S, Ryden M, Lofgren P. et al . Evidence for an important role of perilipin in the regulation of human adipocyte lipolysis.  Diabetologia. 2003;  46 789-797
  • 4 Dicker A, Astrom G, Sjolin E. et al . The influence of preadipocyte differentiation capacity on lipolysis in human mature adipocytes.  Horm Metab Res. 2007;  39 282-287
  • 5 Tai ES, Ordovas JM. The role of perilipin in human obesity and insulin resistance.  Curr Opin Lipidol. 2007;  18 152-156
  • 6 Qi L, Corella D, Sorli JV. et al . Genetic variation at the perilipin (PLIN) locus is associated with obesity-related phenotypes in White women.  Clin Genet. 2004;  66 299-310
  • 7 Kang ES, Cha BS, Kim HJ. et al . The 11482G  > A polymorphism in the perilipin gene is associated with weight gain with rosiglitazone treatment in type 2 diabetes.  Diabetes Care. 2006;  29 1320-1324
  • 8 Qi L, Tai ES, Tan CE. et al . Intragenic linkage disequilibrium structure of the human perilipin gene (PLIN) and haplotype association with increased obesity risk in a multiethnic Asian population.  J Mol Med. 2005;  83 448-456
  • 9 Meirhaeghe A, Thomas S, Ancot F. et al . Study of the impact of perilipin polymorphisms in a French population.  J Negat Results Biomed. 2006;  5 10
  • 10 Hanefeld M, Ceriello A, Schwarz PE, Bornstein SR. The challenge of the metabolic syndrome.  Horm Metab Res. 2007;  39 625-626
  • 11 Schwarz PE, Reimann M, Li J. et al . The metabolic syndrome – a global challenge for prevention.  Horm Metab Res. 2007;  39 777-780
  • 12 Schwarz PE, Bornstein SR, Hanefeld M. Elevated fasting glucose levels predicts IGT and diabetes also in middle-age subjects.  Diabetes Res Clin Pract. 2007;  77 148-150
  • 13 Schwarz PE, Bornstein SR. Pre-diabetes and metabolic syndrome in Germans.  Horm Metab Res. 2006;  38 359
  • 14 Schwarz PE, Towers GW, Fischer S. et al . Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter.  Diabetes Care. 2006;  29 1645-1650
  • 15 Li J, Bergmann A, Reimann M. et al . Genetic variation of neurogenin 3 is slightly associated with hyperproinsulinaemia and progression toward type 2 diabetes.  Exp Clin Endocrinol Diabetes. 2008;  116 178-183
  • 16 Blanchette-Mackie EJ, Dwyer NK, Barber T. et al . Perilipin is located on the surface layer of intracellular lipid droplets in adipocytes.  J Lipid Res. 1995;  36 1211-1226
  • 17 Martinez-Botas J, Anderson JB, Tessier D. et al . Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice.  Nat Genet. 2000;  26 474-479
  • 18 Tansey JT, Sztalryd C, Gruia-Gray J. et al . Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity.  Proc Natl Acad Sci USA. 2001;  98 6494-6499
  • 19 Yan W, Chen S, Huang J. et al . Polymorphisms in PLIN and hypertension combined with obesity and lipid profiles in Han Chinese.  Obes Res. 2004;  12 1733-1737
  • 20 Wang Y, Sullivan S, Trujillo M. et al . Perilipin expression in human adipose tissues: effects of severe obesity, gender, and depot.  Obes Res. 2003;  11 930-936
  • 21 Rooyen JM, Pretorius PJ, Britz M. et al . Genetic polymorphisms of beta2- and beta3-adrenergic receptor genes associated with characteristics of the metabolic syndrome in Black South African Women.  Exp Clin Endocrinol Diabetes. 2008;  116 236-240
  • 22 Schwarz PE, Peltonen M. Prevention of type 2 diabetes – lessons we have learnt for implementation.  Horm Metab Res. 2007;  39 636-641
  • 23 Schwarz PE, Lindstrom J, Kissimova-Scarbeck K. et al . The European Perspective of Type 2 Diabetes Prevention: Diabetes in Europe – Prevention Using Lifestyle, Physical Activity and Nutritional Intervention (DE-PLAN) Project.  Exp Clin Endocrinol Diabetes. 2008;  116 167-172

1 These authors contributed equally to this work.

Correspondence

Dr. P. E. H. Schwarz

Medical Faculty Carl-Gustav-Carus of the Technical University Dresden

Medical Clinic III

Building 10

Room 108

Fetscherstraße 74

01309 Dresden

Germany

Phone: +49/351/458 27 15

Fax: +49/351/458 73 19

Email: peter.schwarz@uniklinikum-dresden.de

    >